[{"NetIncomeLoss_1_Q2_USD":-10263000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8611000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4420000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16657000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":18794000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":11883000.0,"InterestPaidNet_2_Q2_USD":180000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-611000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":75305000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":75305000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1390000.0,"DepreciationAndAmortization_2_Q2_USD":394000.0,"AssetsCurrent_0_Q2_USD":142000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1505244.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":903949.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":816000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":698000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1349000.0,"CommonStockSharesIssued_0_Q2_shares":20610000.0,"Assets_0_Q2_USD":149935000.0,"ShareBasedCompensation_2_Q2_USD":1950000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":5218000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":75305000.0,"ContractWithCustomerLiability_0_Q2_USD":20781000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"DepreciationAndAmortization_1_Q2_USD":200000.0,"OperatingLeaseLiability_0_Q2_USD":5731000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15861000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7944000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":6904000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":3619000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-273000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-121000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2829000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":21000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":6700000.0,"ContractWithCustomerAssetNet_0_Q2_USD":2829000.0,"InterestExpenseLongTermDebt_1_Q2_USD":200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":85721000.0,"DeferredRevenueNoncurrent_0_Q2_USD":14013000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-20040000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-10263000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1442000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":136111000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4394000.0,"Liabilities_0_Q2_USD":56512000.0,"Dividends_2_Q2_USD":0.0,"InterestExpenseLongTermDebt_2_Q2_USD":500000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":992000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1173000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2302000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":4969000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-263000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-100000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2575000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":1950000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1101000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20352000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1427000.0,"LiabilitiesCurrent_0_Q2_USD":23046000.0,"RestrictedCashNoncurrent_0_Q2_USD":107000.0,"DeferredRevenueCurrent_0_Q2_USD":6768000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":136218000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":816000.0,"LongTermDebtNoncurrent_0_Q2_USD":15059000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.084,"AdditionalPaidInCapital_0_Q2_USD":185110000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":1300000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":44000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2610000.0,"NetIncomeLoss_2_Q2_USD":-20040000.0,"AccountsPayableCurrent_0_Q2_USD":4395000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1432000.0,"CommonStockSharesOutstanding_0_Q2_shares":20610000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":64758000.0,"CommonStockSharesAuthorized_0_Q2_shares":30000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":4968000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2322000.0,"OperatingIncomeLoss_2_Q2_USD":-19504000.0,"OperatingIncomeLoss_1_Q2_USD":-10042000.0,"OperatingLeaseCost_2_Q2_USD":900000.0,"OperatingLeaseCost_1_Q2_USD":500000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":149935000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2234000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":7500000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":650000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1950000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":5185000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1337000.0,"OperatingExpenses_2_Q2_USD":24472000.0,"OperatingExpenses_1_Q2_USD":12364000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":674000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.2,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.55,"StockholdersEquity_0_Q2_USD":93423000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":611000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-91708000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1101000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2798000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]